Pharmaceutical company to pay $1 million to settle claims on switching drugs

Share this article:

The Maine subsidiary of Omnicare Pharmacy, a Fortune 500 company, agreed to pay $1 million to settle claims that it switched nursing home patients' prescriptions to a medication that would be more profitable for the company.

Omnicare provides medication for about 7,000 nursing home patients in Maine. The company is accused of creating fake prescriptions to switch patients' heartburn medicine, which meant that the state's Medicaid program paid $82 per month per patient instead of $15.

Patients were switched from tablet form of ranitidine, a generic heartburn medication, to the capsule form. Experts say the two different forms are not therapeutically equivalent.

The company denies the claims but said it settled the charges to avoid extraneous litigation costs.

Share this article:

More in News

Long-term care continues to lead in deal volume and value: PwC report

Long-term care continues to lead in deal volume ...

Long-term care bucked healthcare industry trends with strong merger and acquisition activity in the second quarter of 2014, according to newly released data from professional services firm PricewaterhouseCoopers.

Empowering nurse practitioners could reduce hospitalizations from SNFs, study finds

Granting more authority to nurse practitioners is associated with reduced hospitalization of skilled nursing facility residents, according to recently published findings.

Pioneer ACO drops out of program, despite reductions in skilled nursing utilization

A California healthcare system has become the latest dropout from the Pioneer Accountable Care Organization program, despite reducing skilled nursing facility utilization and improving its readmission rates. Sharp HealthCare announced its decision in a quarterly financial statement released Tuesday.